RadNet earnings release, August 10, 2026

RadNet, Inc. (RDNT) · Form 8-K, Item 2.02 · Filed · SEC filing

RadNet Reports Second Quarter Financial Results with Record Quarterly

Revenue and Adjusted EBITDA

Financial statements

Income Statement

Three Months Ended June 30, — (unaudited) (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Service fee revenue592,589468,0631,137,807907,412
Revenue under capitation arrangements30,13130,16760,54462,217
Total service revenue622,720498,2301,198,351969,629
OPERATING EXPENSESCost of operations, excluding depreciation and amortization534,640429,0851,085,152882,565
OPERATING EXPENSESLease abandonment charges1,3061231,3065,511
OPERATING EXPENSESDepreciation and amortization45,52935,99390,49671,476
OPERATING EXPENSESLoss (gain) on sale and disposal of equipment and other1,1171,7243,7082,126
OPERATING EXPENSESSeverance costs6604262,1241,173
OPERATING EXPENSESTotal operating expenses583,252467,3511,182,786962,851
OPERATING EXPENSESINCOME (LOSS) FROM OPERATIONS39,46830,87915,5656,778
OTHER INCOME AND EXPENSESInterest expense18,15317,18935,81034,428
OTHER INCOME AND EXPENSESEquity in earnings of joint ventures-4,710-4,356-8,535-6,955
OTHER INCOME AND EXPENSESNon-cash change in fair value of interest rate hedge1,9564,062
OTHER INCOME AND EXPENSESDebt restructuring and extinguishment expenses3,3683,368
OTHER INCOME AND EXPENSESOther (income) expenses-3,960-7,764-8,867-15,476
OTHER INCOME AND EXPENSESTotal other (income) expenses12,8517,02521,77616,059
OTHER INCOME AND EXPENSESINCOME (LOSS) BEFORE INCOME TAXES26,61723,854-6,211-9,281
OTHER INCOME AND EXPENSESProvision for income taxes-6,363-8201,7332,578
OTHER INCOME AND EXPENSESNET INCOME (LOSS)20,25423,034-4,478-6,703
OTHER INCOME AND EXPENSESNet income (loss) attributable to noncontrolling interests12,7248,58021,45816,769
OTHER INCOME AND EXPENSESNET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS7,53014,454-25,936-23,472
OTHER INCOME AND EXPENSESBASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS0.10.19-0.33-0.32
OTHER INCOME AND EXPENSESDILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS0.10.19-0.33-0.32
WEIGHTED AVERAGE SHARES OUTSTANDINGBasic77,788,45274,352,49877,425,06174,070,438
WEIGHTED AVERAGE SHARES OUTSTANDINGDiluted78,731,02175,531,74377,425,06174,070,438

Income Statement

Three Months Ended June 30, — (IN THOUSANDS) (in thousands)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income (loss) attributable to Radnet, Inc. common stockholders7,53014,454-25,936-23,472
Income taxes6,363820-1,733-2,578
Interest expense18,15317,18935,81034,428
Severance costs6604262,1241,173
Depreciation and amortization45,52935,99390,49671,476
Non-cash employee stock-based compensation10,5408,74141,91537,235
Loss (gain) on sale and disposal of equipment and other1,1171,7243,7082,126
Non-cash change in fair value of interest rate hedge1,9564,062
Other expenses (income)-3,960-7,764-8,867-15,476
Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI5,1104,7879,6708,349
Lease abandonment charges1,3061231,3065,511
Loss (gain) on extinguishment of debt and related expenses3,3683,368
Non-cash change to contingent consideration-3,157-393
Non-operational rent expenses4984961,3981,838
Acquisition transaction costs6,5992,30110,0532,973
Adjusted EBITDA - Radnet, Inc.99,65681,246162,919127,645
NOTEAdjusted EBITDA - Imaging Center Segment97,17877,843159,138120,531
NOTEAdjusted EBITDA - Digital Health Segment2,4783,4033,7817,114

Balance Sheet

June 30, 2026 — (IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

June 30, 2026 – (unaudited)December 31, 2025
CURRENT ASSETSCash and Cash equivalents726,272767,215
CURRENT ASSETSAccounts receivable241,845200,317
CURRENT ASSETSDue from affiliates6,86312,592
CURRENT ASSETSPrepaid expenses and other current assets60,77652,003
CURRENT ASSETSTotal current assets1,035,7561,032,127
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSProperty and equipment, net879,904807,702
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSOperating lease right-of-use assets759,225690,250
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSTotal property, plant, equipment and right-of-use assets1,639,1291,497,952
OTHER ASSETSGoodwill1,122,468907,663
OTHER ASSETSOther intangible assets245,348148,508
OTHER ASSETSDeferred financing costs1,3931,684
OTHER ASSETSInvestment in joint ventures135,019130,340
OTHER ASSETSDeposits and other47,23840,289
OTHER ASSETSTotal Assets4,226,3513,758,563
CURRENT LIABILITIESAccounts payable, accrued expenses and other489,818422,029
CURRENT LIABILITIESDue to affiliates91,29870,104
CURRENT LIABILITIESDeferred revenue16,4807,272
CURRENT LIABILITIESCurrent operating lease liability69,55761,934
CURRENT LIABILITIESCurrent portion of notes payable30,66925,424
CURRENT LIABILITIESTotal current liabilities697,822586,763
LONG-TERM LIABILITIESLong-term finance lease liability4,288
LONG-TERM LIABILITIESLong-term operating lease liability776,329707,001
LONG-TERM LIABILITIESNotes payable, net of current portion1,301,8621,064,495
LONG-TERM LIABILITIESDeferred tax liability, net39,00521,903

Cash Flow

Original Guidance Range — Digital Health Segment (in millions)

Original Guidance RangeRevised Guidance Range After Q1 ResultsRevised Guidance Range After Q2 Results
Total Net Revenue (inclusive of intersegment revenue)$135 - $145 million$135 - $145 million$135 - $145 million
Adjusted EBITDA(1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$10 - $12 million$10 - $12 million$10 - $12 million
Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$17 - $19 million$17 - $19 million$17 - $19 million
Capital Expenditures$9 - $12 million$9 - $12 million$9 - $12 million
Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(1) - $3 million$(1) - $3 million$(1) - $3 million

Cash Flow

Six Months Ended June 30, — (unaudited) (in thousands)

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net loss-4,478-6,703
Adjustments to reconcile net loss to net cash provided by operating activities:Depreciation and amortization90,49671,476
Adjustments to reconcile net loss to net cash provided by operating activities:Noncash operating lease expense32,65829,356
Adjustments to reconcile net loss to net cash provided by operating activities:Equity in earnings of joint ventures, net of dividends-4,679-1,267
Adjustments to reconcile net loss to net cash provided by operating activities:Amortization of deferred financing costs and loan discount1,5501,471
Adjustments to reconcile net loss to net cash provided by operating activities:Loss on sale and disposal of equipment3,7082,126
Adjustments to reconcile net loss to net cash provided by operating activities:Loss on extinguishment of debt407
Adjustments to reconcile net loss to net cash provided by operating activities:Lease abandonment charges1,3065,511
Adjustments to reconcile net loss to net cash provided by operating activities:Amortization of cash flow hedge2,712
Adjustments to reconcile net loss to net cash provided by operating activities:Non-cash change in fair value of interest rate swap4,062
Adjustments to reconcile net loss to net cash provided by operating activities:Stock-based compensation41,91537,235
Adjustments to reconcile net loss to net cash provided by operating activities:Change in fair value of contingent consideration-393
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Accounts receivable-23,413-14,159
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Other current assets-1,13122,381
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Other assets-7,443-2,544
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Deferred taxes-3,784-3,511
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Operating leases-29,238-34,726
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Deferred revenue1,016145
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Accounts payable, accrued expenses and other74,57448,264
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Net cash provided by operating activities173,071161,829
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of imaging facilities and other acquisitions, net of cash acquired-315,707-31,985
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of property and equipment and other-126,215-101,776
CASH FLOWS FROM INVESTING ACTIVITIESProceeds from sale of equipment74440
CASH FLOWS FROM INVESTING ACTIVITIESEquity contributions in existing and purchase of interest in joint ventures-20,480
CASH FLOWS FROM INVESTING ACTIVITIESCollection of notes receivable6,651
CASH FLOWS FROM INVESTING ACTIVITIESNet cash used in investing activities-434,527-154,201
CASH FLOWS FROM FINANCING ACTIVITIESPrincipal payments on notes and leases payable-11,767-3,461
CASH FLOWS FROM FINANCING ACTIVITIESPayments on Term Loan Debt-11,140-10,252
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from issuance of new debt, net of issuing costs248,93799,001
CASH FLOWS FROM FINANCING ACTIVITIESPurchase of noncontrolling interests by third party2,389
CASH FLOWS FROM FINANCING ACTIVITIESDistributions paid to noncontrolling interests-3,927-3,313
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from issuance of common stock upon exercise of options612554
Full release

(1) and Revises Upwards 2026 Financial Guidance Ranges

LOS ANGELES, California, August 9, 2026 – RadNet, Inc. (NASDAQ: RDNT)

(“RadNet” or the “Company”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2026.

Dr. Howard Berger, President and Chief Executive

Officer of RadNet, commented, “The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results. In the second quarter of 2026, Total Company Revenue grew 25.0% and Digital Health segment

Revenue increased 56.5% from last year’s same quarter. Growth was driven by strong increases in aggregate and same center procedural volumes, the contribution from recent acquisitions, a continuing shift in procedural volumes towards advanced imaging and incremental

Digital Health sales and licenses of Enterprise Imaging and AI solutions.”

Dr. Berger continued, “Within the Imaging

Center operating segment, we continue to have success in driving more advanced imaging procedures and increasing advanced imaging capacity through a variety of operating and Digital Health technology initiatives. Aggregate advanced imaging procedural volumes increased 21.2% and same-center advanced imaging procedural volumes increased 9.6% as compared with the second quarter of 2025. The disproportionally higher growth in MR, CT and PET/CT relative to routine imaging contributed to a 238 basis point shift in RadNet’s advanced imaging procedural volume mix as compared with the same quarter last year, increasing from 27.5% in last year’s second quarter to 29.9% in the second quarter of 2026. This favorable business mix shift contributed to a 16.1% Adjusted EBITDA

(1) margin for the Imaging

Center segment during this year’s second quarter, a 17 basis point improvement as compared with last year’s second quarter.”

“The Digital Health division continues to make significant progress. At June 30, 2026, ARR was $105.5 million, an increase of 97.2% from June 30, 2025 and an increase of 8.9% sequentially from March 31, 2026. ARR generated by external (non- RadNet) customers now comprises approximately 63% of Digital Health Revenue. During the second quarter, we signed new business with Total Contract Value of approximately $21 million, bringing our six-month new business

Total Contract Value to approximately $37 million. The majority of our new business is with hospitals and health systems and spans the full breadth of DeepHealth AI and Enterprise Imaging solutions. On the regulatory front, at the end of July, DeepHealth’s breast ultrasound AI solution was cleared by the FDA. We expect to implement this solution across RadNet’s breast imaging centers by year-end and anticipate both Revenue and cost savings contributions in the second half of this year from the roll-out,” added Dr. Berger.

Dr. Berger continued, “Our joint venture business continues to grow. As of the end of the second quarter, 157 of our 442 locations (or approximately 36%) were held within health system partnerships. During the second quarter, we announced a multi-site joint venture in Boise, Idaho with Trinity Health’s Saint

Alphonsus Health System to initially include the operations of five multimodality outpatient imaging centers. As part of the relationship, our contracted radiology group, Gem State Radiology, and the Saint Alphonsus hospitals in Boise will be adopting a variety of DeepHealth solutions including Diagnostic Suite, Reporting Pro, AI Studio and various clinical AI.”

“Given the positive trends within the industry and RadNet’s strong financial performance of the second quarter, we are revising upwards 2026 Imaging Center guidance levels for

Revenue, Adjusted EBITDA

(1) and Free Cash Flow

(2) in anticipation of financial results that we believe will exceed both our original expectations and the amendments we made to the guidance ranges upon releasing first quarter 2026 results in May,” concluded Dr. Berger.

Second Quarter Financial Results

For the second quarter of 2026, RadNet reported

Total Company Revenue of $622.7 million and Adjusted EBITDA

(1) of $99.7 million. Revenue increased $124.5 million (or 25.0%) and Adjusted EBITDA

(1) increased $18.4 million (or 22.7%) as compared with the second quarter of 2025.

For the second quarter of 2026, RadNet reported

Digital Health Revenue (inclusive of intersegment revenue) of $32.4 million and Adjusted EBITDA

(1) of $2.5 million. Revenue increased $11.7 million (or 56.5%) and Adjusted EBITDA

(1) decreased $0.9 million (or 27.2%) as compared with the second quarter of 2025. The decrease in Digital Health Adjusted EBITDA

(1) resulted predominantly from investments in headcount to fuel growth in sales, marketing, customer service and implementation teams. At June 30, 2026, Annual Recurring Revenue

(4)

(ARR) for Digital

Health was $105.5 million, as compared with $53.5 million as of June 30, 2025.

Unadjusted for unusual or one-time items impacting the second quarter of 2026, Total Company Net Income for the second quarter of 2026 was $7.5 million as compared with a Total Company

Net Income of $14.5 million for the second quarter of 2025. Net Income Per Share for the second quarter of 2026 was $0.10, compared with a Net Income per share of $0.19 in the second quarter of 2025, based upon a weighted average number of diluted shares outstanding of 78.7 million shares in 2026 and 75.5 million shares in 2025.

There were a number of unusual or one-time items... (truncated)lities under construction that have yet to open their operations; $5.1 million of non-capitalized research and development expenses with respect to DeepHealth solutions; $6.8 million of Intangibles amortization within the Digital Health division primarily related recent acquisitions; $1.3 million of lease abandonment charges; $6.6 million of acquisition transaction costs; $3.2 million gain on the change in contingent consideration related to recent acquisitions; and $3.4 million loss from debt restructuring and extinguishment related to our recent debt repricing transaction. Adjusting for the above items, Total Company Adjusted Earnings

(3) was $23.2 million and diluted Adjusted Earnings Per Share

(3) was $0.29 during the second quarter of 2026. This compares with Total Company Adjusted Earnings

(3) of $25.7 million and diluted

Adjusted Earnings Per Share

(3) of $0.34 during the second quarter of 2025.

For the second quarter of 2026, as compared with the prior year’s second quarter, MRI volume increased 21.0%, CT volume increased 20.9%, PET/CT volume increased 31.0% and routine imaging (inclusive of nuclear medicine, ultrasound, mammography, x-ray and other exams) increased 7.9% over the prior year’s second quarter. On a same-center basis, including only those centers which were part of RadNet for both the second quarters of 2026 and 2025,

MRI volume increased 10.2%, CT volume increased 8.6%, PET/CT volume increased 8.8% and routine imaging increased 1.7% over the prior year’s second quarter.

Six Month Financial Results

For the first six months of 2026, RadNet reported

Total Company Revenue of $1,198 million and Adjusted EBITDA

(1) of $162.9 million. Revenue increased $228.7 million (or 23.6%) and Adjusted EBITDA

(1) increased $35.3 million (or 27.6%) as compared with the first six months of 2025.

For the first six months of 2026, RadNet reported

Digital Health Revenue (inclusive of intersegment revenue) of $61.5 million and Adjusted EBITDA

(1) of $3.8 million. Revenue increased $21.6 million (or 54.1%) and Adjusted EBITDA

(1) decreased $3.3 million (or 46.9%) as compared with the first six months of 2025.

Unadjusted for one-time or unusual items, Total

Company Net Loss for the first six months of 2026 was $25.9 million as compared with a Total Company Net Loss of $23.5 million for the first six months of 2025. Net Loss Per Share for the six-month period of 2026 was $(0.33), compared with a Net Loss per share of $(0.32) in the six-month period of 2025, based upon a weighted average number of diluted shares outstanding of 77.4 million shares in 2026 and

74.1 million shares in 2025.

2026 Guidance Update

RadNet updates guidance levels as follows:

Imaging Center Segment

Digital Health Segment

Conference Call for Tomorrow

Dr. Howard Berger, President and Chief Executive

Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its second quarter

2026 results on Monday, August 10th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Conference Call Details:

Date: Monday, August 10, 2026

Time: 7:30 a.m. Pacific Time (10:30 a.m. Eastern

Time)

Dial In-Number: 844-744-1280

International Dial-In Number: 412-564-6465

It is recommended that participants dial in approximately 5 minutes prior to the start of the call. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1770869&tp_key=f4d7c2481f or http://www.radnet.com under the “News” menu section of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10210872.

About RadNet, Inc.

RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue.

RadNet has a network of owned and operated outpatient imaging centers. RadNet’s markets include Arizona, California, Delaware, Florida,

Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has a total of over 11,000 employees. For more information, visit http://www.radnet.com.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, guidance and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,”

“project,” “estimate,” “expect,” “strategy,” “future,” “likely,”

“may,” “should,” “will” and similar references to future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue... (truncated)t could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet’s filings with the United States Securities and Exchange Commisssion

(the “SEC”), including the risk factors discussed in RadNet’s most recent Annual Report on Form 10-K, as updated by its Quarterly

Reports on Form 10-Q and future filings with the SEC.

Any forward-looking statement contained in this release is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

Regulation G: GAAP and Non-GAAP Financial

Information

This release contains certain financial information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company’s financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial

Officer

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · RadNet earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.